Cargando…
Cardiovascular outcomes of liraglutide in patients with type 2 diabetes: A systematic review and meta-analysis
BACKGROUND: Liraglutide is a novel, long-acting glucagon-like peptide-1 (GLP-1) analogue used to treat type 2 diabetes mellitus. However, the cardiovascular safety and benefits of liraglutide treatment on type 2 diabetes patients remain in debate. In this study, we aimed to examine the overall cardi...
Autores principales: | Duan, Chun-Mei, Wan, Teng-Fei, Wang, Yue, Yang, Qing-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867782/ https://www.ncbi.nlm.nih.gov/pubmed/31725627 http://dx.doi.org/10.1097/MD.0000000000017860 |
Ejemplares similares
-
Outcome of Frozen Elephant Trunk Technique for Acute Type A Aortic Dissection: As Systematic Review and Meta-Analysis
por: Lin, Hui-Han, et al.
Publicado: (2015) -
Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus: A PRISMA-compliant systematic review and meta-analysis
por: lv, Xiaodan, et al.
Publicado: (2018) -
Comparative efficacy of 5 sodium glucose cotransporter 2 inhibitor and 7 glucagon-like peptide 1 receptor agonists interventions on cardiorenal outcomes in type 2 diabetes patients: A network meta-analysis based on cardiovascular or renal outcome trials
por: Duan, Xue-Yan, et al.
Publicado: (2021) -
Cardiovascular outcomes in patients with co-existing coronary artery disease and rheumatoid arthritis: A systematic review and meta-analysis
por: Wang, Hong, et al.
Publicado: (2020) -
Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
por: Lee, Mei-Chuan, et al.
Publicado: (2022)